Melissa Barber: The ongoing legal fight to win affordable, sustainable access to risdiplam in India
Melissa Barber, Postdoctoral at Yale Law School, shared a post on X:
“I spoke to Rema Nagarajan at The Times of India about drug cost transparency and the ongoing legal fight to win affordable, sustainable access to risdiplam in India.”
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, reshared the post, adding:
“Some great insights on the cost of prescription drugs, an issue I’m passionate about. Agree with much of this.”
Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023